Les Meilleurs Tumeur surrénale pour le traitement de tumeur surrénale en Israël - TOP-7 des médecins

Le professeur Merimsky dirige l'unité d'oncologie des tissus mous et des os au centre médical Sourasky, se spécialisant dans les tumeurs rares et complexes.

• Plus de 30 ans d'expérience en oncologie, avec une spécialisation dans les sarcomes
• Formation spécialisée à l'Institut Gustave Roussy à Paris pour le traitement des sarcomes
• Membre de la faculté de l'ESMO pour les sarcomes des tissus mous et des os
• Mener des recherches approfondies en immunologie tumorale et en thérapies ciblées

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Le Dr Levin coordonne le programme national sur le sarcome pédiatrique, traitant les cancers des os et des tissus mous. Il a étudié dans un centre d'oncologie orthopédique de premier plan en Italie.

• Pédiatre senior avec une spécialisation en hématologie et oncologie pédiatriques
• Directeur du département d'hématologie et d'oncologie pédiatriques au centre médical Sourasky
• Se concentrer sur le traitement des troubles sanguins et des cancers chez les enfants
• Membre de la Société israélienne d'hématologie et d'oncologie pédiatriques (ISPHO)
• Diriger un service pour les troubles de la coagulation et de la thrombose

Directeur de l'hospitalisation oncologique au centre médical Ichilov de Tel Aviv, le Dr Stepfansky dirige des études cliniques en oncologie de phases 1 à 3.

• Se spécialiser en médecine interne et en oncologie
• Avoir plus de 20 ans d'expérience clinique en oncologie
• Être chercheur principal et secondaire dans des essais cliniques en oncologie
• Pratiquer à l'Université de Grodno et au centre médical de Mozir

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.